1. Home
  2. MOMO vs ALVO Comparison

MOMO vs ALVO Comparison

Compare MOMO & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hello Group Inc.

MOMO

Hello Group Inc.

HOLD

Current Price

$6.18

Market Cap

971.4M

Sector

Technology

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.45

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOMO
ALVO
Founded
2011
2013
Country
China
Luxembourg
Employees
N/A
1460
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.4M
1.1B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MOMO
ALVO
Price
$6.18
$3.45
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
521.0K
334.6K
Earning Date
06-04-2026
05-06-2026
Dividend Yield
4.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
$3.68
$18.63
P/E Ratio
$10.60
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$3.03
52 Week High
$9.22
$11.85

Technical Indicators

Market Signals
Indicator
MOMO
ALVO
Relative Strength Index (RSI) 51.35 47.58
Support Level $5.69 $3.03
Resistance Level $6.32 $3.93
Average True Range (ATR) 0.17 0.17
MACD 0.00 0.00
Stochastic Oscillator 38.39 34.37

Price Performance

Historical Comparison
MOMO
ALVO

About MOMO Hello Group Inc.

Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: